CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 1,404,622,000 shares (grant or award)
- NT 10-Q Other NT 10-Q
- 8-K Event Material agreement · Acquisition or sale completed · Delisting notice · Unregistered share sale · Executive or director change · Regulation FD disclosure
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 425 Deal Prospectus/Communication re Business Combination
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Delisting notice
- 4 Derivatives Options or other derivatives
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 9 of 38 · 746 filings